Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Closure of Atrial Septal Defects With the AMPLATZER Septal Occluder - Post Approval Study

Study:

n/a

Rationale:

n/a

Purpose:

The purpose of this study is to prospectively evaluate the incidence of hemodynamic compromise and to obtain long-term survival data on patients with the AMPLATZER Septal Occluder

Study Status: Active, not recruiting

Recruiting:
n/a

Condition Intervention Phase
Atrial Septal Defect Device: AMPLATZER Septal Occluder N/A

Verified by AGA Medical Corporation March, 2013

Sponsored by: AGA Medical Corporation
Information provided by: AGA Medical Corporation
ClinicalTrials.gov identifier: NCT00650936

Study Type: Interventional

Study Design: Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

The Children`s Hospital at Cleveland Clinic
Cleveland, Ohio 44195
United States

n/a

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.